Literature DB >> 1814327

Virological markers in the cerebrospinal fluid from HIV-1-infected individuals.

R Buffet1, H Agut, F Chieze, C Katlama, F Bolgert, A Devillechabrolle, B Diquet, E Schuller, C Pierrot-Deseilligny, M Gentilini.   

Abstract

We analysed 127 specimens of cerebrospinal fluid (CSF) from 118 HIV-1-infected individuals at different stages of infection. Intrathecal antibody synthesis was evident in 23 samples tested and was more frequently directed against HIV than against rubella virus, herpes simplex virus, varicella zoster virus or cytomegalovirus. HIV was isolated from only 14% of the 127 CSF specimens, but from 82% of CSF-paired blood samples. HIV antigen was detected in 12% of CSF specimens and 44% of paired plasma samples. Twenty specimens analysed using the polymerase chain reaction (PCR) detected proviral DNA in 75% of CSF specimens. The low rate of virus recovery from CSF was caused by neither the freezing of specimens prior to culture nor therapy. In contrast, virus isolation from CSF was significantly associated with CSF cell count. Virus isolation and antigen detection in CSF were not correlated with either the Centers for Disease Control disease stage or the peripheral CD4+ lymphocyte count, whereas viraemia was significantly associated with a low CD4+ lymphocyte count. Moreover, virus isolation and antigen detection in CSF were not associated with symptoms of subacute HIV encephalitis, suggesting that these markers are not of potential value in the diagnosis of HIV-specific neurologic complications. The value of PCR in this field merits further investigation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1814327     DOI: 10.1097/00002030-199112000-00002

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  7 in total

1.  Cerebrospinal fluid pleocytosis as a predictive factor for CSF and plasma HIV RNA discordance and escape.

Authors:  Sérgio Monteiro de Almeida; Indianara Rotta; Ana Paula de Pereira; Bin Tang; Anya Umlauf; Cléa Elisa Lopes Ribeiro; Scott Letendre; Ronald J Ellis
Journal:  J Neurovirol       Date:  2020-01-30       Impact factor: 2.643

2.  Subclinical reactivation of varicella zoster virus in all stages of HIV infection.

Authors:  Marius Birlea; Gabriele Arendt; Eser Orhan; D Scott Schmid; William J Bellini; Christian Schmidt; Don Gilden; Randall J Cohrs
Journal:  J Neurol Sci       Date:  2011-03-17       Impact factor: 3.181

Review 3.  NeuroAIDS: characteristics and diagnosis of the neurological complications of AIDS.

Authors:  Alireza Minagar; Deborah Commins; J Steven Alexander; Romy Hoque; Francesco Chiappelli; Elyse J Singer; Behrooz Nikbin; Paul Shapshak
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

4.  Comparative analysis of intrathecal antibody synthesis and DNA amplification for the diagnosis of cytomegalovirus infection of the central nervous system in AIDS patients.

Authors:  T Weber; R Beck; E Stark; J Gerhards; K Korn; J Haas; W Lüer; G Jahn
Journal:  J Neurol       Date:  1994-06       Impact factor: 4.849

Review 5.  Human immunodeficiency virus type 1 infection of the brain.

Authors:  W J Atwood; J R Berger; R Kaderman; C S Tornatore; E O Major
Journal:  Clin Microbiol Rev       Date:  1993-10       Impact factor: 26.132

6.  HIV Dementia.

Authors:  Avindra Nath; Joseph Berger
Journal:  Curr Treat Options Neurol       Date:  2004-03       Impact factor: 3.972

Review 7.  Compartmentalized intrathecal immunoglobulin synthesis during HIV infection - a model of chronic CNS inflammation?

Authors:  Mickael Bonnan; Bruno Barroso; Stéphanie Demasles; Elsa Krim; Raluca Marasescu; Marie Miquel
Journal:  J Neuroimmunol       Date:  2015-05-16       Impact factor: 3.478

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.